Evidence map›Paper›PMID 30893315›Full record

ArticlePLoS genetics2019

Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.

Lina Ding, Lauren B Shunkwiler, Nicholas W Harper, Yang Zhao, Kunihiko Hinohara, Sung Jin Huh, Muhammad B Ekram, Jan Guz, Michael J Kern, Alexander Awgulewitsch and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Lina DingDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Lauren B ShunkwilerDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0003-2632-7610
Nicholas W HarperDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0002-4037-7473
Yang ZhaoDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0002-4303-1240
Kunihiko HinoharaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Sung Jin HuhDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Muhammad B EkramDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0001-5555-6872
Jan GuzDepartment of Regenerative Medicine and Cell Biology, Transgenic and Gene Function Core, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Michael J KernDepartment of Regenerative Medicine and Cell Biology, Transgenic and Gene Function Core, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Alexander AwgulewitschDepartment of Medicine, Transgenic and Gene Function Core, Medical University of South Carolina, Charleston, South Carolina, United States of America.
James D ShullDepartment of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0003-4537-5159
Bart M G SmitsDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0003-3806-2357
Kornelia PolyakDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0002-5964-0382
Medical University of South Carolina · USHarvard University · USDana-Farber Cancer Institute · USUniversity of Wisconsin–Madison · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of ClonalP01CA080111 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEINBERG, ROBERT A · 1999 to 2018
$36.0M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 2012 to 2016
$5.5M
GENETIC SUSCEPTIBILITY TO ESTROGEN INDUCED MAMMARY CAR01CA077876 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SHULL, JAMES D · 1998 to 2012
$4.4M
Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk LocusR01CA204320 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SHULL, JAMES D · 2017 to 2021
$2.1M
NCI NIH HHS P01 CA080111NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA077876NCI NIH HHS R01 CA204320NIGMS NIH HHS P30 GM103342
6 · The paper itself

Abstract

Mammary epithelial progenitors are the normal cell-of-origin of breast cancer. We previously defined a population of p27+ quiescent hormone-responsive progenitor cells in the normal human breast whose frequency associates with breast cancer risk. Here, we describe that deletion of the Cdkn1b gene encoding the p27 cyclin-dependent kinase inhibitor in the estrogen-induced mammary tumor-susceptible ACI rat strain leads to a decrease in the relative frequencies of Cd49b+ mammary luminal epithelial progenitors and pregnancy-related differentiation. We show by comprehensive gene expression profiling of purified progenitor and differentiated mammary epithelial cell populations that p27 deletion has the most pronounced effects on luminal progenitors. Cdkn1b-/- females have decreased fertility, but rats that are able to get pregnant had normal litter size and were able to nurse their pups implying that loss of p27 in ACI rats does not completely abrogate ovarian function and lactation. Reciprocal mammary gland transplantation experiments indicate that the p27-loss-induced changes in mammary epithelial cells are not only caused by alterations in their intrinsic properties, but are likely due to altered hormonal signaling triggered by the perturbed systemic endocrine environment observed in Cdkn1b-/- females. We also observed a decrease in the frequency of mammary epithelial cells positive for progesterone receptor (Pr) and FoxA1, known direct transcriptional targets of the estrogen receptor (Erα), and an increase in phospho-Stat5 positive cells commonly induced by prolactin (Prl). Characterization of genome-wide Pr chromatin binding revealed distinct binding patterns in mammary epithelial cells of Cdkn1b+/+ and Cdkn1b-/- females and enrichment in genes with known roles in Notch, ErbB, leptin, and Erα signaling and regulation of G1-S transition. Our data support a role for p27 in regulating the pool size of hormone-responsive luminal progenitors that could impact breast cancer risk.

Indexed as

AnimalsAnimals, Genetically ModifiedBreast NeoplasmsCell DifferentiationCell ProliferationCyclin-Dependent Kinase Inhibitor p27Endocrine CellsEpithelial CellsEstrogen Receptor alphaEstrogensFemaleGenetic Predisposition to DiseaseHumansIntegrin alpha1Mammary Glands, AnimalMammary Glands, HumanCDKN1B protein, humanCdkn1b protein, ratCyclin-Dependent Kinase Inhibitor p27Estrogen Receptor alphaEstrogensIntegrin alpha1ProgesteroneReceptors, EstrogenReceptors, Progesterone

Identifiers

PMID30893315
PMCPMC6443185
OpenAlexW2923784055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.